Acura Pharmaceuticals Inc.


Acura Pharmaceuticals, Inc. (ACUR) To Delist From NASDAQ; Shares Fall 23%

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) investors are running for the hills, after the drug announced that its shares will be delisted from the NASDAQ Stock …

Stock Update (NASDAQ:ACUR): Acura Pharmaceuticals, Inc. Provides Development Update on its LIMITx(TM) Technology

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) announced that the U.

Company Update (NASDAQ:ACUR): Acura Pharmaceuticals, Inc’s LIMITX(TM) Technology Successfully Confirms Oral Abuse Deterrence Capabilities

Acura Pharmaceuticals, Inc (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that topline results from cohort 2 of clinical study AP-LTX-400 …

Company Update (NASDAQ:ACUR): Acura Pharmaceuticals, Inc. Announces First Quarter 2016 Financial Results

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, announced today financial results for the first quarter ended March 31, 2016.

Analysts Weigh in on Clovis Oncology Inc (CLVS) and Acura Pharmaceuticals, Inc. (ACUR) Following FDA Updates

Healthcare analysts commented on Clovis Oncology Inc (NASDAQ:CLVS) and Acura Pharmaceuticals, Inc. (NASDAQ:ACUR) following an FDA Committee decision and an FDA Fast Track designation, respectively.

Company Update (NASDAQ:ACUR): Acura Pharmaceuticals, Inc. Announces FDA Fast Track Designation for the Development of LTX-04

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that the U.

Stock Update (NASDAQ:ACUR): Acura Pharmaceuticals, Inc. Provides Development Update on Its LIMITX(TM) Abuse Deterrent Technology

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced that clinical testing of its lead LIMITX™ oral abuse deterrent …

Company Update (NASDAQ:ACUR): Acura Pharmaceuticals, Inc. Announces Third Quarter 2015 Financial Results

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), a specialty pharmaceutical company developing products intended to address medication abuse and misuse, announced today financial results for the …

Stock Update (NASDAQ:ACUR): Acura Pharmaceuticals, Inc. Receives $2.5 Million Milestone Payment From Egalet Corporation

Acura Pharmaceuticals, Inc. (NASDAQ:ACUR), announced the receipt of a $2.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts